Netherlands· NL-331c3bca0caa
Prismasol 2 mmol/l Kalium, oplossing voor hemodialyse/hemofiltratie
A hemofiltrates product containing calcium (ca2+) + calciumchloride 2-water (e 509) + chloride (cl-) + glucose 0-water, registered in Netherlands by Vantive Belgium SRL. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Calcium (ca2+) + calciumchloride 2-water (e 509) + chloride (cl-) + glucose 0-water is registered in 11 of 19 countries.
Countries holding a registration under ATC B05ZB (hemofiltrates), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Calcium (ca2+) + calciumchloride 2-water (e 509) + chloride (cl-) + glucose 0-water · ATC B05ZB
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- CALCIUM (Ca2+) + CALCIUMCHLORIDE 2-WATER (E 509) + CHLORIDE (CL-) + GLUCOSE 0-WATER
- Manufacturer
- Vantive Belgium SRL
- Country
- Netherlands (NL)
- ATC code
- B05ZB
- ATC class
- Hemofiltrates
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id28876
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B05ZB
Hemofiltrates, as other registers publish it.
- BelgiumAccusol 35Nikkiso Belgium
- BelgiumAccusol 35 Kalium 2 mmol/lNikkiso Belgium
- BelgiumAccusol 35 Kalium 4 mmol/lNikkiso Belgium
- IrelandAccusol 35 Potassium 2 mmol/lSolution for haemofiltration, haemodialysis and haemodiafiltrationNikkiso Belgium bvba
- IrelandAccusol 35 Potassium 4 mmol/lSolution for haemofiltration, haemodialysis and haemodiafiltrationNikkiso Belgium bvba
- IrelandAccusol 35 Solution for haemofiltration, haemodialysis and haemodiafiltrationNikkiso Belgium bvba
- FinlandBicaflac BufferB. Braun Avitum AG
- FinlandBicaflac Cum KaliumB. Braun Avitum AG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fadc1a9d-2e4b-45fb-8c8d-485aeb68afdd GET /v1/drugs/fadc1a9d-2e4b-45fb-8c8d-485aeb68afdd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor hemodialyse, Oplossing voor hemofiltratie",
"route": "Hemodialyse",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h28876_smpc.pdf",
"strength": null,
"atc_label": "Hemofiltrates",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg28876",
"excipients": [
"KOOLSTOFDIOXIDE (E 290)",
"WATER, GEZUIVERD",
"WATER, GEZUIVERD"
],
"substances": [
"CALCIUM (Ca2+)",
"CALCIUMCHLORIDE 2-WATER (E 509)",
"CHLORIDE (CL-)",
"GLUCOSE 0-WATER",
"GLUCOSE 1-WATER",
"KALIUM (K+)",
"KALIUMCHLORIDE (E 508)",
"LACTAAT (R,S) (-)",
"MAGNESIUM (MG2+)",
"MAGNESIUMCHLORIDE 6-WATER (E 511)",
"MELKZUUR (D,L,+- VORM) (E 270)",
"NATRIUM (NA+)",
"NATRIUMCHLORIDE",
"NATRIUMWATERSTOFCARBONAAT (E 500 (II))",
"WATERSTOFCARBONAAT (HCO3-)"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h28876.pdf",
"authorised_at": "2003/09/04",
"procedure_number": "FR/H/0226/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "28876",
"additional_monitoring": "N"
}See everything about calcium (ca2+) + calciumchloride 2-water (e 509) + chloride (cl-) + glucose 0-water.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.